Bayer flags major Phase III results for stroke prevention drug asundexian
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
The new outpatient-focused clinic is designed to address voice, airway and swallowing disorders through advanced diagnostics
The goal is to better support drug developers as programs move from laboratory research into clinical trials
The collaboration will embed OpenAI’s advanced AI systems across Novo Nordisk’s global operations
Strategic expansion strengthens CDMO’s support for biotech and pharma innovators across the Asia-Pacific region
AI-enabled women’s digital clinic brings in-person consultations to complement app-led care after serving over 400,000 women across India
Benefits were consistent across all key subgroups, including patients previously treated with covalent BTK inhibitors
Effective recovery at home begins with well-defined care plans that outline treatment protocols, recovery milestones, and monitoring requirements tailored to individual patient needs
Subscribe To Our Newsletter & Stay Updated